Epigenetic DNA Modifications Upregulate SPRY2 in Human Colorectal Cancers
Conventional wisdom is that Sprouty2 (SPRY2), a suppressor of Receptor Tyrosine Kinase (RTK) signaling, functions as a tumor suppressor and is downregulated in many solid tumors. We reported, for the first time, that increased expression of SPRY2 augments cancer phenotype and Epithelial-Mesenchymal-...
Main Authors: | Alexei J. Stuckel, Shuai Zeng, Zhen Lyu, Wei Zhang, Xu Zhang, Urszula Dougherty, Reba Mustafi, Qiong Zhang, Trupti Joshi, Marc Bissonnette, Samrat Roy Choudhury, Sharad Khare |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/10/2632 |
Similar Items
-
Enhanced CXCR4 Expression Associates with Increased Gene Body 5-Hydroxymethylcytosine Modification but not Decreased Promoter Methylation in Colorectal Cancer
by: Alexei J. Stuckel, et al.
Published: (2020-02-01) -
Sprouty4 is epigenetically upregulated in human colorectal cancer
by: Alexei J. Stuckel, et al.
Published: (2023-12-01) -
Role of SPRY4 in health and disease
by: Hao Pan, et al.
Published: (2024-04-01) -
An Immunosensor for the Determination of Cortisol in Serum and Saliva by Array SPRi
by: Anna Sankiewicz, et al.
Published: (2022-12-01) -
An Array SPRi Biosensor for the Determination on PARP-1 in Blood Plasma
by: Zuzanna Zielinska, et al.
Published: (2023-02-01)